Chemoinformaics analysis of 2-Ethyl-5-methylpyrazine
Molecular Weight | 122.171 | nRot | 1 |
Heavy Atom Molecular Weight | 112.091 | nRig | 1 |
Exact Molecular Weight | 122.084 | nRing | 1 |
Solubility: LogS | -7.381 | nHRing | 1 |
Solubility: LogP | 11.788 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 1 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 19 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 9 | No. of Aromatic Carbocycles | 0 |
nHetero | 2 | No. of Aromatic Hetero Cycles | 1 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 7 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 2 | No. of Arom Atom | 6 |
No. of Oxygen atom | 0 | No. of Arom Bond | 6 |
nHA | 2 | APOL | 20.5579 |
nHD | 0 | BPOL | 12.3121 |
QED | 0.127 |
Synth | 1.686 |
Natural Product Likeliness | 0.273 |
NR-PPAR-gamma | 0.657 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Rejected |
Golden Triangle | Rejected |
Pgp-inh | 0 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -5.252 |
MDCK | 0.00000399 |
BBB | 0.004 |
PPB | 0.979803 |
VDSS | 3.344 |
FU | 0.0072101 |
CYP1A2-inh | 0.041 |
CYP1A2-sub | 0.143 |
CYP2c19-inh | 0.11 |
CYP2c19-sub | 0.047 |
CYP2c9-inh | 0.027 |
CYP2c9-sub | 0.976 |
CYP2d6-inh | 0.057 |
CYP2d6-sub | 0.032 |
CYP3a4-inh | 0.174 |
CYP3a4-sub | 0.015 |
CL | 4.706 |
T12 | 0.051 |
hERG | 0.53 |
Ames | 0.005 |
ROA | 0.012 |
SkinSen | 0.96 |
Carcinogencity | 0.019 |
EI | 0.911 |
Respiratory | 0.844 |
NR-Aromatase | 0.073 |
Antiviral | No |
Prediction | 0.904905 |